20 October 2024 in Nature Communications
Synthetic lethality (SL) is a gold mine of anticancer drug targets, exposing cancer-specific dependencies of cellular survival. To complement resource-intensive experimental screening, many machine learning methods for SL prediction have emerged recently. However, a comprehensive benchmarking is lacking. This study systematically benchmarks 12 recent machine learning methods for SL prediction, assessing their performance across diverse data splitting scenarios, negative sample ratios, and negative sampling techniques, on both classification and ranking tasks. We observe that all the methods can perform significantly better by improving data quality, e.g., excluding computationally derived SLs from training and sampling negative labels based on gene expression. Among the methods, SLMGAE performs the best. Furthermore, the methods have limitations in realistic scenarios such as cold-start independent tests and context-specific SLs. These results, together with source code and datasets made freely available, provide guidance for selecting suitable methods and developing more powerful techniques for SL virtual screening.
6 October 2025 in IEEE Transactions on Computational Biology and Bioinformatics
Predicting biomedical interactions is crucial for understanding various biological processes and drug discovery. Graph neural networks (GNNs) are promising in identifying novel interactions when extensive labeled data are available. However, labeling biomedical interactions is often time-consuming and labor-intensive, resulting in low-data scenarios. Furthermore, distribution shifts between training and test data in real-world applications pose a challenge to the generalizability of GNN models. Recent studies suggest that pre-training GNN models with self-supervised learning on unlabeled data can enhance their performance in predicting biomedical interactions. Here, we propose LukePi, a novel self-supervised pre-training framework that pre-trains GNN models on biomedical knowledge graphs (BKGs). LukePi is trained with two self-supervised tasks: topology-based node degree classification and semantics-based edge recovery. The former is to predict the degree of a node from its topological context and the latter is to infer both type and existence of a candidate edge by learning semantic information in the BKG. By integrating the two complementary tasks, LukePi effectively captures the rich information from the BKG, thereby enhancing the quality of node representations. We evaluate the performance of LukePi on two critical link prediction tasks: predicting synthetic lethality and drug-target interactions, using four benchmark datasets. In both distribution-shift and low-data scenarios, LukePi significantly outperforms 22 baseline models, demonstrating the power of the graph pre-training strategy when labeled data are sparse.
13 February 2025 in bioRxiv
Predicting biomedical interactions is crucial for understanding various biological processes and drug discovery. Graph neural networks (GNNs) are promising in identifying novel interactions when extensive labeled data are available. However, labeling biomedical interactions is often time-consuming and labor-intensive, resulting in low-data scenarios. Furthermore, distribution shifts between training and test data in real-world applications pose a challenge to the generalizability of GNN models. Recent studies suggest that pre-training GNN models with self-supervised learning on unlabeled data can enhance their performance in predicting biomedical interactions. Here, we propose LukePi, a novel self-supervised pre-training frame-work that pre-trains GNN models on biomedical knowledge graphs (BKGs). LukePi is trained with two self-supervised tasks: topology-based node degree classification and semantics-based edge recovery. The former is to predict the degree of a node from its topological context and the latter is to infer both type and existence of a candidate edge by learning semantic information in the BKG. By integrating the two complementary tasks, LukePi effectively captures the rich information from the BKG, thereby enhancing the quality of node representations. We evaluate the performance of LukePi on two critical link prediction tasks: predicting synthetic lethality and drug-target interactions, using four benchmark datasets. In both distribution-shift and low-data scenarios, LukePi significantly outperforms 15 baseline models, demonstrating the power of the graph pre-training strategy when labeled data are sparse.
13 February 2025 in Nature Communications